ArticleInternational ophthalmology2025
Application of cardiopulmonary coupled sleep monitoring technology in sleep analysis of glaucoma patients.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveTo assess sleep quality of glaucoma patients using cardiopulmonary coupled CPC monitoring.
methods276 patients from July 2021 to May 2022 were continuously collected. 176 patients including 95 patients with acute angle-closure glaucoma (group A) and 81 patients with chronic angle-closure glaucoma (group B) were enrolled, 100 cataract patients (group C) as the control group. The CPC monitoring was performed on the enrolled patients. According to diseases types and CPC results, the sleep quality of the glaucoma patients was analyzed.
resultsThe total sleep time (TST) of group A was 6.91 ± 1.471 h, while Group B's TST was 7.14 ± 0.637 h. Group C's TST was 7.45 ± 0.852 h. The sleep efficiency (TIB) of group A was 80.128 ± 10.959, and group B's TIB was 80.246 ± 9.936. Group C's TIB was 85.451 ± 6.534. The Apnea-Hypopnea Index (AHI) of group A was 17.923 ± 19.901, and group B's AHI was 15.438 ± 15.818. Group C's AHI was 9.481 ± 10.494. The difference between the group A and group B was statistically significant, and the differences among the group A, B and the group C was statistically significant in the three sets of data.
conclusionsPACG patients, especially with acute presentation (PAACG), demonstrate significantly disrupted sleep and higher AHI versus controls via CPC monitoring. These findings advocate for embedding sleep-disordered breathing screening into routine glaucoma management using CPC as a practical triage tool.
Indexed as
Identifiers
40694253What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.